APA (7th ed.) Citation

A, K., V, B., CM, S., ML, B., O, V., A, T., . . . I, H. (2026). B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer. ImmunoTargets and therapy, 15, 577364. https://doi.org/10.2147/ITT.S577364

Chicago Style (17th ed.) Citation

A, Kielbik, et al. "B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer." ImmunoTargets and Therapy 15 (2026): 577364. https://doi.org/10.2147/ITT.S577364.

MLA (9th ed.) Citation

A, Kielbik, et al. "B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer." ImmunoTargets and Therapy, vol. 15, 2026, p. 577364, https://doi.org/10.2147/ITT.S577364.